XML 25 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheet Account Detail
6 Months Ended
Jun. 30, 2014
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Account Detail
Balance Sheet Account Detail

(a) Property and Equipment

Property and equipment consisted of the following:
 
June 30,
2014
 
December 31,
2013
Production equipment, molds, and office furniture
$
8,577

 
$
8,033

Computer hardware and software
3,725

 
3,290

Leasehold improvements
3,055

 
3,058

Construction in progress (software and related implementation, production equipment, and leasehold improvements)
12,651

 
2,594

Property and equipment, at cost
$
28,008

 
$
16,975

Accumulated depreciation
(10,606
)
 
(9,637
)
Property and equipment, net
$
17,402

 
$
7,338



Depreciation expense for property and equipment for the three months ended June 30, 2014, and 2013 was $0.5 million, and $0.7 million respectively. For the six months ended June 30, 2014, and 2013 depreciation expense for property and equipment was $1.0 million, and $1.1 million respectively.

(b) Inventories

Inventories consisted of the following:
 
June 30,
2014
 
December 31,
2013
Raw materials
$
5,081

 
$
3,793

Work-in-process
7,848

 
4,539

Finished goods
15,555

 
11,226

Inventories
$
28,484

 
$
19,558



(c) Goodwill and Intangible Assets

The following table presents goodwill, indefinite lived intangible assets, finite lived intangible assets, and related accumulated amortization:
 

June 30,
2014

December 31,
2013
Goodwill (1)
$
29,086


$
29,103







Intangible assets:





Indefinite lived intangibles





Trademarks and trade names
$
2,708


$
2,708







Finite lived intangibles





Developed technology (2)
$
40,100


$
40,100

Accumulated amortization
(182
)

(48
)
Developed technology, net
$
39,918


$
40,052







Patent
$
100


$
100

Accumulated amortization
(100
)

(95
)
Patent, net
$


$
5







License
$
100


$
100

Accumulated amortization
(57
)

(41
)
License, net
$
43


$
59







Customer relationships
$
539


$
544

Accumulated amortization
(359
)

(272
)
Customer relationships, net
$
180


$
272







Intangible assets (excluding goodwill), net
$
42,849


$
43,096

(1) Difference in goodwill value between these dates is solely due to a foreign currency translation adjustment.
(2) Was reclassified in the first quarter of 2013 from in-process research and development to finite lived intangibles, which coincided with the European commercial launch of the product (Nellix EVAS System) associated with this intangible asset. A significant portion of this intangible asset will not begin amortization until the U.S. launch of this product, currently scheduled for 2016.
Amortization expense for intangible assets for the three months ended June 30, 2014, and 2013 was $0.1 million, and $0.1 million respectively. For the six months ended June 30, 2014, and 2013 amortization expense for intangible assets was $0.2 million, and $0.1 million respectively.
Estimated amortization expense for the five succeeding years and thereafter (which includes amortization of intangible assets which commenced in February 2013 with the commercial launch of the Nellix System in Europe) is as follows:

Amortization Expense
Remainder of 2014
$
238

2015
655

2016
980

2017
2,315

2018
3,976

2019
4,650

2020 & Thereafter
27,327

Total
$
40,141


(d) Marketable securities

Investments in held-to-maturity marketable securities consist of the following at June 30, 2014:

June 30, 2014

Amortized
Cost

Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair Value
Corporate and other debt securities
$
79,764


$
13

 
$
(5
)

$
79,772



At June 30, 2014, the Company’s investments included 12 held-to-maturity debt securities in unrealized loss positions with a total unrealized loss of approximately $5 thousand and a total fair market value of approximately $79.8 million. All investments with gross unrealized losses have been in unrealized loss positions for less than 6 months. The unrealized losses were caused by interest rate fluctuations. There was no change in the credit risk of the securities. The Company does not intend to sell the securities and it is not likely that the Company will be required to sell the securities before the expected recovery of their amortized cost bases. There were no realized gains or losses on the investments for the three and six months ended June 30, 2014.

(e) Fair Value Measurements

The following fair value hierarchy table presents information about each major category of the Company’s assets and liabilities measured at fair value on a recurring basis as of June 30, 2014:
 
Quoted prices in
active markets for
identical assets
(Level 1)

Significant other
observable
inputs
(Level 2)

Significant
unobservable
inputs
(Level 3)

Total
At December 31, 2013











Cash and cash equivalents
$
95,152


$


$


$
95,152

Contingently issuable common stock
$


$


$
60,900


$
60,900

At June 30, 2014











Cash and cash equivalents
$
31,843


$


$


$
31,843

Contingently issuable common stock
$


$


$
14,500


$
14,500



There were no re-measurements to fair value during the six months ended June 30, 2014 of financial assets and liabilities that are not measured at fair value on a recurring basis. There were no transfers between Level 1, Level 2, or Level 3 securities during the six months ended June 30, 2014.

(f) Instruments Not Recorded at Fair Value on a Recurring Basis

We measure the fair value of our Senior Notes carried at amortized cost quarterly for disclosure purposes. The estimated fair value of the Senior Notes is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar issues. Based on the market prices, the fair value of our long-term debt was $87.2 million as of June 30, 2014 and $84.9 million as of December 31, 2013.

We measure the fair value of our held-to-maturity marketable securities carried at amortized cost quarterly for disclosure purposes. The fair value of certain marketable securities is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar instruments.